Johnson & Johnson: Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...
The Malaysian Reserve

Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the ...

How Gavin Newsom got under Trump’s skin – with jokes

Hollywood looks, humour and pushback have put the spotlight on California’s governor. Who is Trump’s “critic in chief”?

Swipe, swab, ship: How at-home tests are changing the way we think about wellness

Can your bathroom double as a lab? At-home testing is reshaping how we learn about our bodies — and raising new questions.
The Punch on MSN

Unusual cough, fever stir panic in Lagos

NCDC on alert as COVID-19 deaths rise in UK•Medical experts urge testing, cautionForty-two-year-old Lagos resident, Kabir Adeoye, has been battling persistent fever and related symptoms despite ...
C&EN

mRNA vaccine builds viruslike nanoparticles inside the body

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...
Harrow Times

UK Government urged to ‘do the right thing’ and reject Rosebank development

Equinor, which owns the majority of the oil field, stressed it was committed to advancing the ‘Rosebank project’.